絞り込み

16636

広告

Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.

著者 Marote A , Pomeshchik Y , Goldwurm S , Collin A , Lamas NJ , Pinto L , Salgado AJ , Roybon L
Stem Cell Res.2018 Jan 04 ; 27():90-94.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (19view , 0users)

Full Text Sources

Medical

Research Materials

ULUNDi006-A (CVCL_RV28)

Mutations in the PARK2 gene, which encodes PARKIN, are the most frequent cause of autosomal recessive Parkinson's disease (PD). We report the generation of an induced pluripotent stem cell (iPSC) line from a 78-year-old patient carrying a compound heterozygous mutation (c.823C>T and EX6del) in the PARK2 gene. Skin fibroblasts were reprogrammed using the non-integrating Sendai virus technology to deliver OCT3/4, SOX2, c-MYC and KLF4 factors. The generated cell line CSC-44 exhibits expression of common pluripotency markers, in vitro differentiation into the three germ layers and normal karyotype. This iPSC line can be used to explore the association between PARK2 mutations and PD.
PMID: 29353703 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード